- Home
- TOPS vs ISPC Comparison
TOPS vs ISPC Comparison
Compare TOPS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOPS | ISPC |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | Greece | United States |
| Employees | N/A | 7 |
| Industry | Marine Transportation | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.2M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TOPS | ISPC |
|---|---|---|
| Price | $0.30 | $0.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 594.9K | 59.3K |
| Earning Date | 09-16-2026 | 11-16-2026 |
| Dividend Yield | ★ 287.62% | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | N/A | $638.10 |
| Revenue Next Year | N/A | $17.50 |
| P/E Ratio | $2.14 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.79 |
| 52 Week High | $7.40 | $115.00 |
Technical Indicators
Market Signals| Indicator | TOPS | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 22.20 | 27.75 |
| Support Level | N/A | N/A |
| Resistance Level | $1.29 | $1.15 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.24 | 9.14 |
Price Performance
Historical ComparisonAbout TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.